Results 221 to 230 of about 1,245,601 (334)
The Surgery of Portal Hypertension [PDF]
openaire +4 more sources
This review outlines the potential role of anti‐GPCR autoantibodies in MASLD/MASH, given their involvement in a wide range of diseases and their possible contribution to MASLD/MASH pathophysiology. We also focused on anti‐ApoA1 autoantibodies, sharing functional features with anti‐GPCR autoantibodies and have been shown to promote liver steatosis in ...
Sabrina Pagano+3 more
wiley +1 more source
Understanding clinically significant portal hypertension: an in-depth look at pathogenesis, diagnosis and treatment. [PDF]
Vanderschueren E+2 more
europepmc +1 more source
Abstract Aim Antithrombin (AT), a plasma protein with anticoagulant properties, has a long‐standing medical history, primarily for treatment of congenital AT deficiency. Accumulated clinical experiences suggest AT is a potential anticoagulant for thrombotic diseases. This study aimed to clarify the effectiveness, safety, and clinical significance of AT
Shoichi Matsutani+2 more
wiley +1 more source
Case Report: Successful surgical intervention for portal hypertension caused by primary hypoplasia of the portal vein in a dog. [PDF]
Shin JH, Han HJ.
europepmc +1 more source
Hepatocellular carcinoma (HCC) in the hepatitis C virus (HCV)‐sustained virologic response (SVR) group was associated with alcohol consumption and metabolic diseases and showed significantly lower rates of ARID2 alterations and AXIN1 alterations compared to the HCV‐non‐SVR group, with a mutational profile resembling that of the steatotic liver disease ...
Fukiko Kawai‐Kitahata+21 more
wiley +1 more source
Relative change rate of liver stiffness measurements predicts the risk of liver decompensation in compensated advanced chronic liver disease. [PDF]
Li Y+6 more
europepmc +1 more source